| Serial Number | 88232854 |
| Word Mark | TADAQOR |
| Filing Date | Tuesday, December 18, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 25, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 23, 2019 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 9, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teva Pharmaceuticals USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | Teva Pharmaceuticals USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | North Wales, PA 19454 |
| Event Date | Event Description |
| Monday, July 25, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, July 25, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, December 24, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 23, 2021 | SOU EXTENSION 5 GRANTED |
| Monday, December 13, 2021 | SOU EXTENSION 5 FILED |
| Thursday, December 23, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, December 13, 2021 | TEAS EXTENSION RECEIVED |
| Saturday, June 19, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 17, 2021 | SOU EXTENSION 4 GRANTED |
| Thursday, June 17, 2021 | SOU EXTENSION 4 FILED |
| Thursday, June 17, 2021 | TEAS EXTENSION RECEIVED |
| Friday, December 18, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 16, 2020 | SOU EXTENSION 3 GRANTED |
| Wednesday, December 16, 2020 | SOU EXTENSION 3 FILED |
| Wednesday, December 16, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, June 13, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 11, 2020 | SOU EXTENSION 2 GRANTED |
| Thursday, June 11, 2020 | SOU EXTENSION 2 FILED |
| Thursday, June 11, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, December 14, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 12, 2019 | SOU EXTENSION 1 GRANTED |
| Thursday, December 12, 2019 | SOU EXTENSION 1 FILED |
| Thursday, December 12, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, June 18, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 23, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 23, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 3, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, March 14, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, March 14, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, January 9, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, December 21, 2018 | NEW APPLICATION ENTERED IN TRAM |